Literature DB >> 28564011

EXPERIMENTAL STUDIES OF PLEIOTROPY AND EPISTASIS IN ESCHERICHIA COLI. II. COMPENSATION FOR MALADAPTIVE EFFECTS ASSOCIATED WITH RESISTANCE TO VIRUS T4.

Richard E Lenski1.   

Abstract

Mutations in Escherichia coli that confer resistance to virus T4 also have maladaptive effects that reduce competitive fitness. After resistant populations had evolved for 400 generations in the absence of T4, their fitness approached that of sensitive populations allowed to evolve under identical conditions. However, the resistant populations had not reverted to sensitivity. Instead, this convergence in fitness resulted from genetic changes that compensated for maladaptive pleiotropic effects of the resistance mutations. An allele selected in an evolving resistant population reduced the competitive disadvantage associated with resistance by almost half. Interestingly, this allele was also beneficial in sensitive populations, although its fitness advantage was only about one-fifth as great as it was in the resistant population. These results run counter to a commonly held view that trade-offs between components of fitness should become more pronounced as populations approach their "selective equilibria." If a trade-off derives from some limiting energetic or material currency, then it is likely to become more pronounced as a population becomes more finely adapted. If a trade-off derives from the disruption of genetic integration, then it is likely to be diminished with further adaptation. © 1988 The Society for the Study of Evolution.

Entities:  

Year:  1988        PMID: 28564011     DOI: 10.1111/j.1558-5646.1988.tb04150.x

Source DB:  PubMed          Journal:  Evolution        ISSN: 0014-3820            Impact factor:   3.694


  20 in total

1.  Evolution of adaptive phenotypic variation patterns by direct selection for evolvability.

Authors:  Mihaela Pavlicev; James M Cheverud; Günter P Wagner
Journal:  Proc Biol Sci       Date:  2010-11-24       Impact factor: 5.349

2.  Elevated lytic phage production as a consequence of particle colonization by a marine Flavobacterium (Cellulophaga sp.).

Authors:  Lasse Riemann; Hans-Peter Grossart
Journal:  Microb Ecol       Date:  2008-03-18       Impact factor: 4.552

3.  Experimental investigation of an RNA sequence space.

Authors:  Y H Lee; L Dsouza; G E Fox
Journal:  Orig Life Evol Biosph       Date:  1993-12       Impact factor: 1.950

4.  The evolution of phenotypic correlations and "developmental memory".

Authors:  Richard A Watson; Günter P Wagner; Mihaela Pavlicev; Daniel M Weinreich; Rob Mills
Journal:  Evolution       Date:  2014-02-01       Impact factor: 3.694

Review 5.  Evaluating the fate of genetically modified microorganisms in the environment: are they inherently less fit?

Authors:  R E Lenski
Journal:  Experientia       Date:  1993-03-15

6.  Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli.

Authors:  Zachary D Blount; Christina Z Borland; Richard E Lenski
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-04       Impact factor: 11.205

7.  Convergent evolution toward an improved growth rate and a reduced resistance range in Prochlorococcus strains resistant to phage.

Authors:  Sarit Avrani; Debbie Lindell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-14       Impact factor: 11.205

8.  Virus-host swinging party in the oceans: Incorporating biological complexity into paradigms of antagonistic coexistence.

Authors:  Sarit Avrani; Daniel A Schwartz; Debbie Lindell
Journal:  Mob Genet Elements       Date:  2012-03-01

9.  Characterization of lysogens in bacterioplankton assemblages of the southern California borderland.

Authors:  Ian Hewson; Jed A Fuhrman
Journal:  Microb Ecol       Date:  2007-03-08       Impact factor: 4.192

10.  Experimental evolution with E. coli in diverse resource environments. I. Fluctuating environments promote divergence of replicate populations.

Authors:  Tim F Cooper; Richard E Lenski
Journal:  BMC Evol Biol       Date:  2010-01-13       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.